Release Agreements in the Pharmaceuticals Industry

102 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (3 contracts)
Acer Therapeutics Inc. (1)
Adamis Pharmaceuticals Corp (2)
Akorn (1)
APRICUS BIOSCIENCES, INC. (1)
Aquestive Therapeutics, Inc. (1)
Aralez Pharmaceuticals Inc. (1)
ARIAD PHARMACEUTICALS INC (1)
Assertio Therapeutics, Inc (6)
Astex Pharmaceuticals, Inc (1)
AUXILIUM PHARMACEUTICALS INC (3)
BARR PHARMACEUTICALS INC (1)
Bausch Health Companies Inc. (1)
Bespoke Extracts, Inc. (1)
Biofrontera Inc. (1)
CHIASMA, INC (1)
Citius Pharmaceuticals, Inc. (3)
Clever Leaves Holdings Inc. (1)
COSMO VENTURES INC (1)
Cure Pharmaceutical Holding Corp. (1)
DUSA PHARMACEUTICALS INC (2)
Eloxx Pharmaceuticals, Inc. (3)
EPIX Pharmaceuticals, Inc. (2)
Exactus, Inc. (1)
EyePoint Pharmaceuticals, Inc. (1)
FRONTIER OILFIELD SERVICES INC (1)
Harmony Biosciences Holdings, Inc. (1)
HARROW HEALTH, INC. (1)
Horizon Pharma plc (3)
Innoviva, Inc. (2)
Intra-Cellular Therapies, Inc. (0)
Jazz Pharmaceuticals plc (1)
Kannalife Inc (3)
Lexaria Bioscience Corp. (4)
Lilly (Eli) & Co. (1)
Mallinckrodt (2)
MEMORY PHARMACEUTICALS CORP (3)
MJ Holdings, Inc. (1)
Neuralstem, Inc. (2)
NovaBay Pharmaceuticals, Inc. (2)
OPIANT PHARMACEUTICALS, INC. (1)
PANACOS PHARMACEUTICALS, INC. (1)
Perrigo (2)
Phibro Animal Health Corporation (1)
PLAYERS NETWORK (2)
PONIARD PHARMACEUTICALS, INC. (1)
PROTEO INC (2)
RADIENT PHARMACEUTICALS Corp (1)
RespireRx Pharmaceuticals Inc. (1)
Roivant Sciences Ltd. (1)
SALIX PHARMACEUTICALS LTD (1)
Supernus Pharmaceuticals, Inc. (3)
TAPESTRY PHARMACEUTICALS, INC (1)
Terra Tech Corp. (2)
Textmunication Holdings, Inc. (1)
Theravance Biopharma, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (2)
VALEANT PHARMACEUTICALS INTERNATIONAL (2)
Verrica Pharmaceuticals Inc. (0)
VIA Pharmaceuticals, Inc. (1)
ZOGENIX, INC. (6)

Recent Contracts

Form of Consent and Release, dated March 24, 2024 (NovaBay Pharmaceuticals, Inc., Filed With SEC on March 25, 2024)
Release of Claims, dated February 13, 2024, between the Company, Pharma and Bioscience (Biofrontera Inc., Filed With SEC on February 20, 2024)
Release and Assignment Agreement dated November 10, 2023, by and between the Issuer and PUR Life Medical, Inc (Exactus, Inc., Filed With SEC on February 5, 2024)
Amendment to Forbearance Agreement, dated as of August 15, 2023, by and among ST US AR Finance LLC, Barclays Bank plc, as administrative agent and collateral agent, and the... (Mallinckrodt, Filed With SEC on August 15, 2023)
Forbearance Agreement, dated as of July 16, 2023, by and among ST US AR Finance LLC, Barclays Bank plc, as administrative agent and collateral agent, and the Lenders comprising... (Mallinckrodt, Filed With SEC on July 17, 2023)
Acknowledgment and Release Agreement, dated January 20, 2023, by and between Harmony Biosciences Holdings, Inc. and John C. Jacobs (Harmony Biosciences Holdings, Inc., Filed With SEC on February 21, 2023)
Release Agreement, dated as of July 13, 2022, by and among Innoviva, Inc., Innoviva TRC Holdings LLC, Royalty Pharma Investments 2019 ICAV, Theravance Respiratory Company, LLC,... (Theravance Biopharma, Inc., Filed With SEC on July 14, 2022)
Press Release issued May 26, 2022 (Adamis Pharmaceuticals Corp, Filed With SEC on May 26, 2022)
Press Release dated April 28, 2022 (COSMO VENTURES INC, Filed With SEC on April 29, 2022)
Release and Waiver of Claims of Barry Moze, dated as of January 10, 2022 (Horizon Pharma plc, Filed With SEC on March 1, 2022)
Release and Waiver of Claims of Brian Beeler, dated as of January 6, 2022 (Horizon Pharma plc, Filed With SEC on March 1, 2022)
Press Release (Bespoke Extracts, Inc., Filed With SEC on December 8, 2021)
Agreement and General Release Between Roivant Sciences Ltd., Roivant Sciences, Inc. and Benjamin Zimmer (Roivant Sciences Ltd., Filed With SEC on November 15, 2021)
Press Release dated October 4, 2021 (Adamis Pharmaceuticals Corp, Filed With SEC on October 4, 2021)
Payout and Release Agreement, dated as of July 13, 2021, by and among Clever Leaves International Inc., Clever Leaves Holdings Inc., GLAS Americas LLC, as collateral agent, GLAS... (Clever Leaves Holdings Inc., Filed With SEC on July 19, 2021)
Agreement and General Release, dated as of July 2, 2021, by and between Neil S. Belloff and Eloxx Pharmaceuticals, Inc (Eloxx Pharmaceuticals, Inc., Filed With SEC on July 6, 2021)
Mutual Rescission Agreement and General Release entered into as of May 14, 2021 by and between TRICCAR, Inc. (formerly Frontier Oilfield Services Inc.), a Nevada corporation and... (FRONTIER OILFIELD SERVICES INC, Filed With SEC on June 1, 2021)
Cooperation and Release Agreement Richard S. Groberg, RSG Advisors, LLC and MJ Holdings, Inc. dated May 12, 2021 (MJ Holdings, Inc., Filed With SEC on May 18, 2021)
Release Agreement, effective as of February 9, 2021, by and between Eli Lilly and Company and Joshua L. Smiley (Lilly (Eli) & Co., Filed With SEC on April 30, 2021)
Form of Resignation and Release Agreement (Terra Tech Corp., Filed With SEC on January 25, 2021)
Form of Resignation and Release Agreement (Terra Tech Corp., Filed With SEC on January 25, 2021)
Press Release of Opiant Press Release of Opiant Pharmaceuticals, Inc., dated November 12, 2020, Inc., dated November 12, 2020 (OPIANT PHARMACEUTICALS, INC., Filed With SEC on November 12, 2020)
Release Agreement, dated September 2, 2014, between the Company and the Institute for the Study of Aging Inc (RespireRx Pharmaceuticals Inc., Filed With SEC on October 14, 2020)
Release of Claims, dated September 30, 2020, between the Company and Mark J. Fitzpatrick (CHIASMA, INC, Filed With SEC on October 1, 2020)
Release, Waiver and Amendment (Cure Pharmaceutical Holding Corp., Filed With SEC on June 9, 2020)
Release and Waiver of Claims of Robert F. Carey, dated as of September 18, 2019 (Horizon Pharma plc, Filed With SEC on November 6, 2019)
Press Release Dated September 25, 2019 (Supernus Pharmaceuticals, Inc., Filed With SEC on September 25, 2019)
Press Release Dated August 26, 2019 (Supernus Pharmaceuticals, Inc., Filed With SEC on August 26, 2019)
Supplemental Waiver and Release Agreement by and between Perrigo Company plc and Ronald Winowiecki effective as of July 1, 2019 (Perrigo, Filed With SEC on August 8, 2019)
Press Release Dated July 23, 2019 (Supernus Pharmaceuticals, Inc., Filed With SEC on July 23, 2019)
Agreement and General Release between Theravance Biopharma US, Inc. and Shehnaaz Suliman, dated March 1, 2019 (Theravance Biopharma, Inc., Filed With SEC on May 10, 2019)
Waiver and Release Agreement by and between Perrigo Company plc and Ronald Winowiecki effective as of April 17, 2019 (Perrigo, Filed With SEC on May 9, 2019)
December 31, 2018 Release Agreement and Agreement to Rescind and Extinguish Asset Purchase Agreement and Side Letter Agreement Dated May 24, 2018 (PLAYERS NETWORK, Filed With SEC on February 1, 2019)
Release of Claims by and between the Company and Brian Dorsey, dated August 30, 2018 (APRICUS BIOSCIENCES, INC., Filed With SEC on August 31, 2018)
LOCK-UP AND LEAK-OUT AND RELEASE AGREEMENT (Kannalife Inc, Filed With SEC on July 31, 2018)
LOCK-UP AND LEAK-OUT AND RELEASE AGREEMENT (Kannalife Inc, Filed With SEC on July 31, 2018)
LOCK-UP AND LEAK-OUT AND RELEASE AGREEMENT (Kannalife Inc, Filed With SEC on July 31, 2018)
General Release of All Claims, dated as of November 30, 2017, by and between Scott J. Charles, POZEN, Inc. and Aralez Pharmaceuticals Inc (Aralez Pharmaceuticals Inc., Filed With SEC on March 14, 2018)
Release Agreement, dated November 7, 2017, between Citius Pharmaceuticals, Inc., and Aegis Capital Corp (Citius Pharmaceuticals, Inc., Filed With SEC on February 14, 2018)
Waiver and Release Agreement dated July 12, 2017 by and between the Company and Thadd M. Vargas (Assertio Therapeutics, Inc, Filed With SEC on November 9, 2017)